Skip to content

Replimune Group REPL Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$198.6M+10.6%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.06M+246%
Immunome logo
ImmunomeIMNM
$5.1M+199%
CG Oncology logo
CG OncologyCGON
$8.07M+1,377%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$3.03M-254%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.3M+454%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's increase (decrease) in prepaid expense and other assets?
Replimune Group (REPL) reported increase (decrease) in prepaid expense and other assets of -$36K in Q4 2025.
How has Replimune Group's increase (decrease) in prepaid expense and other assets changed year-over-year?
Replimune Group's increase (decrease) in prepaid expense and other assets increased by 92.9% year-over-year, from -$506K to -$36K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.